Discovery of potent and orally active tricyclic-based FBPase inhibitors

Introduction of prodrug moieties into tricyclic-based FBPase inhibitors led to the discovery of prodrug 15c, which strongly inhibited glucose production in monkey hepatocytes. Furthermore, prodrug 15c lowered blood glucose levels in fasted cynomolgus monkeys.